Performance of the EQ-5D in Patients with Irritable Bowel Syndrome

Abstract

The EQ-5D performs well in comparison to general and disease-specific outcomes. It is a valid and responsive measure that can be used to generate preference-based valuations of HRQoL in patients with IBS and useful for comparisons in clinical and cost-effectiveness studies.

The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial

“…Th ose who failed the PASS test (that is, had continued refl ux symptoms despite prescription medication) were asked to complete further questionnaires. Th ese included demographic information, a global overall symptom (GOS) rating with the patient rating their overall symptoms on a sevenpoint adjectival scale over the previous 2 days, a validated refl ux symptom questionnaire (the Refl ux Disease Questionnaire) ( 14 ), and a validated general quality of life instrument (Euroqol, EQ-5D) that can derive utility estimates that can be used to express the data in terms of QALYs ( 15 ). Data were obtained from the primary care record on current prescribed refl ux medications.…”

Relief of Periorbital Pain After Acute Angle Closure Glaucoma Attack by Botulinum Toxin Type A

“…The EQ-5D was developed by a group of European-based researchers to assess a given health state via an index score. 4 The EQ-5D includes 1 health state descriptive system and 1 visual analog rating scale (VARS). The health-state descriptive system covered 5 dimensions of health (mobility, self-care, usual activities, pain/discomfort, and anxiety/depression), and participants were directed to score each dimension in 1 of 3 ways: no problem, some/ moderate problems, or extreme problems/unable.…”

Coping with celiac disease: how heavy is the burden for caregivers?

“…VAS is a simple effective tool in surveys, with different studies showing its psychometric properties for the assessment of stress, and is as valid, reliable and responsive as multi-item scales (25,26). Its application has already been validated in other gastrointestinal and extra-intestinal conditions (27)(28)(29)(30), in order to measure the burden of the disease on quality of life.…”